Search the Newsreel

Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL) Given Average Recommendation of "Hold" by Brokerages

Twelve brokerages have issued an average "Hold" recommendation for Cracker Barrel Old Country Store, Inc. (NASDAQ:CBRL), with an average 12-month target price of $48.14. The company recently reported better-than-expected quarterly earnings of $0.29 per share against an anticipated loss, despite a 2.9% year-over-year revenue …

Prelude Therapeutics (PRLD) Expected to Post Earnings on Thursday

Prelude Therapeutics (PRLD) is projected to release its Q2 2026 earnings before market open on Thursday, August 13th. Analysts anticipate a loss of $0.17 per share on revenue of $4.78 million. In the prior quarter, the company surpassed earnings estimates with a loss of …

Relay Therapeutics Q2 Results: Sales drop 48% YoY, miss estimates

Relay Therapeutics reported a significant miss on its Q2 analyst estimates, with EPS of $(0.41) against an expected $(0.39). Sales plummeted 48.30% year-over-year to $350,000, falling short of the $872,727 estimate by nearly 60%. This performance indicates considerable top-line pressure and highlights operational challenges, …

Relmada Q2 2026 earnings: R&D spending rises ahead of planned IND filings

Relmada Therapeutics reported a wider net loss of $12.9 million in Q2 2026, despite a narrowed GAAP loss per share, driven by a nearly threefold increase in R&D expenses to $8.4 million. The company is prioritizing manufacturing and regulatory preparations for its NDV-01 and …

Earnings call transcript: Relmada posts Q2 2026 EPS beat as shares slip

Relmada Therapeutics reported a narrower-than-expected Q2 2026 loss of $0.11 per share, beating analyst estimates, but its shares fell due to investor focus on drug development timelines and higher research spending. The company's lead drug, NDV-01 for bladder cancer, and sepranolone for Prader-Willi syndrome, …

Barclays Maintains RELX PLC(RLXXF.US) With Buy Rating, Cuts Target Price to $41.71

Barclays has reiterated its Buy rating for RELX PLC (RLXXF.US) but has adjusted its price target downwards to $41.71. This indicates that while the firm still views RELX as a favorable investment, its valuation has been slightly revised.

Earnings Flash (RLAY) Relay Therapeutics Posts Q2 Loss $0.41 per Share, vs. FactSet Est of $0.39 Loss

Relay Therapeutics (RLAY) reported a Q2 loss of $0.41 per share, which is higher than FactSet's estimated loss of $0.39 per share. The company also announced Q2 revenue of $400,000. Relay Therapeutics is a clinical-stage precision medicine company focused on developing therapies for cancer …

Relay Therapeutics Q2 2026 earnings: Clinical spending rises with cash runway into 2029

Relay Therapeutics reported Q2 2026 revenue of $0.4 million, a decrease from the previous year, with a net loss of $83.7 million due to increased spending on clinical trials. Despite the wider loss, a May equity offering boosted cash reserves to $910.9 million, providing …

Earnings Flash (RLAY) Relay Therapeutics, Inc. Reports Q2 Revenue $400,000

Relay Therapeutics, Inc. (RLAY) announced its Q2 revenue of $400,000. This news follows another report indicating the company posted a Q2 loss of $0.41 per share, which was higher than FactSet's estimate of a $0.39 loss. The company is a clinical-stage precision medicine firm …

Relmada Therapeutics (Nasdaq: RLMD) details Q2 2026 loss and NDV-01 Phase 3 path

Relmada Therapeutics reported a net loss of $12.9 million for Q2 2026, alongside a business update on its oncology and CNS pipeline. The company is advancing its lead candidate, NDV-01, for non-muscle invasive bladder cancer towards a Phase 3 registrational program, with an IND …

Form 8K Relmada Therapeutics Inc For: 6 August By Investing.com

This article reports on the filing of a Form 8K by Relmada Therapeutics Inc. on August 6th. The content is brief and serves primarily as an announcement of this regulatory filing, likely containing important company updates.

REG - RELX PLC - Director/PDMR Shareholding

This article reports a Director/PDMR shareholding notification for RELX PLC. Rosemary Thomson, a PDMR, acquired 910 Ordinary Shares on August 3, 2026, at a price of £19.76 per share. This acquisition resulted from the exercise of an option granted under the RELX Group plc …

Reliance Global Group (NASDAQ: EZRA) sells 251,666 shares for $716K

JBT Marel declares $0.10 quarterly dividend By Investing.com

JBT Marel Corporation (JBTM) has announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share of outstanding common stock. This dividend is payable on August 31, 2026, to stockholders of record as of August 17, 2026. JBT Marel is …

Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Lags Revenue Estimates

Relay Therapeutics, Inc. (RLAY) reported a Q2 loss of $0.41 per share, meeting the Zacks Consensus Estimate but missing revenue estimates significantly at $0.35 million. Despite underperforming revenue expectations over the last four quarters, the stock has seen a 132.7% increase year-to-date, contrasting with …

Relay Therapeutics Inc (RLAY) News, Articles, Events & Latest Updates

This article compiles recent news and updates for Relay Therapeutics Inc (RLAY), including its Q2 2026 earnings report showing a loss and missed revenue estimates. Other news highlights include an insider stock sale topping $3 million, an AI biotech reporting significant revenue jump, and …

Earnings Miss: JBT Marel Corporation Missed EPS By 51% And Analysts Are Revising Their Forecasts

JBT Marel Corporation (NYSE:JBTM) reported a significant 51% earnings per share miss in its latest second-quarter results, although revenues were in line with analyst predictions. Following these results, analysts have slightly lowered their EPS forecasts for 2026, though revenue estimates remained largely unchanged. Despite …

RELX PLC To Go Ex-Dividend On August 7th, 2026 With 0.27851 USD Dividend Per Share

RELX PLC is set to go ex-dividend on August 7th, 2026, with a dividend payment of 0.27851 USD per share. Investors looking to receive this dividend must own shares before the ex-dividend date.

Pacer Advisors Inc. Has $8.16 Million Position in G-III Apparel Group, LTD. $GIII

Pacer Advisors Inc. reduced its stake in G-III Apparel Group (NASDAQ:GIII) by 16.2% in the first quarter, now holding 294,427 shares valued at $8.16 million. The company reported better-than-expected quarterly earnings despite an 8.2% year-over-year revenue decline and provided fiscal 2027 earnings guidance. G-III …

FMR LLC and Abigail Johnson disclose 9.4% Relay Therapeutics (RLAY) ownership in 13G

FMR LLC and Abigail Johnson have disclosed a 9.4% beneficial ownership in Relay Therapeutics (RLAY) through a Schedule 13G filing. This represents 20,015,113.24 shares of common stock as of June 30, 2026. FMR LLC holds sole voting power over 19,967,458 shares and sole dispositive …

Here's How Much a $1000 Investment in Reliance Made 10 Years Ago Would Be Worth Today

How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors and industries. The fear of missing out, or FOMO, also plays a factor in …

RELX PLC (NYSE: RELX) PDMR exercises option to acquire ordinary shares

RELX PLC reported that Rosemary Thomson, a Person Discharging Managerial Responsibilities (PDMR), acquired 910 Ordinary Shares at £19.76 per share on August 3, 2026. This acquisition resulted from the exercise of an option granted on June 14, 2023, under the RELX Group plc 2023 …

RELX slides Thursday, underperforms market

Shares of RELX PLC (REL) fell on Thursday, underperforming the broader market. The stock dropped 3.38% to £26.03, while the FTSE 100 Index (UKX) saw a smaller decline. RELX PLC is now trading significantly below its 52-week high.

Form 8K Reliance Global Group Inc For: 6 August By Investing.com

This article announces that Reliance Global Group Inc. filed a Form 8K on August 6th. The content is a brief notification from Investing.com and provides no further details about the filing itself. It is surrounded by general financial market data, news headlines, and advertising …

Ambarella, Inc. $AMBA Shares Purchased by Sei Investments Co.

Sei Investments Co. increased its holdings in Ambarella, Inc. by 38.4% in Q1, owning 89,139 shares valued at $4.6 million. Institutional investors collectively hold 82.09% of the company's stock, and analysts have a "Moderate Buy" rating with a target price above its current share …

Dorel Industries Q2 2026 Earnings Call Transcript

Key Points Interested in Dorel Industries Inc? Here are five stocks we like better. Dorel's Q2 revenue fell 14.7% to $42.9 million lower year over year, but the operating loss improved to $24.3 million from $37.2 million. Excluding restructuring and foreign-exchange effects, management said …

Reliance Steel stock hits all-time high at 421.15 USD

Reliance Steel & Aluminum Co. (RS) stock has achieved an all-time high of $421.15, marking a 48.12% increase over the past year. This milestone follows impressive Q2 2026 results where the company surpassed Wall Street expectations, attributing its success to strong sales and a …

Relx Plc (NYSE:RELX) Given Average Rating of "Moderate Buy" by Analysts

Eight analysts have given Relx Plc (NYSE:RELX) a consensus "Moderate Buy" rating, with four buy recommendations, one strong buy, and three holds. Institutional investors have modestly increased their holdings, collectively owning 15.02% of the company. The company also announced a dividend of $0.2785 payable …

RELX PLC (RELX) Gewinnprognose: Zukünftige EPS & Umsatzwachstumsprognosen

Maurel & Prom : Résultats du premier semestre 2026

ETFs Investing in Ambarella, Inc. Stocks

This article provides a comprehensive list of Exchange Traded Funds (ETFs) that hold Ambarella, Inc. stocks, detailing each fund's market value, weight, issuer, management style, focus, expense ratio, assets under management (AUM), price, change, and 3-year NAV total return. The ETFs listed range from …

JBT Marel Corp (JBTM) Stock Down 7.9% -- Now Undervalued? GF Sco

JBT Marel Corp (JBTM) stock recently dropped 7.9% to $122.01, placing it 21.9% below its GF Value™ estimate of $156.13, suggesting it is undervalued despite its P/E ratio being higher than its historical median. The company has a strong GF Score™ of 84/100, indicating …

Reliance Global Group signs LOI to sell Altruis for $11M, targets debt-free balance sheet

Reliance Global Group (EZRA) announced a non-binding Letter of Intent (LOI) to sell substantially all operating assets of Altruis Benefit Consulting for $11 million in cash. The transaction aims to retire approximately $4.4 million in term debt and generate about $7.6 million in incremental …

JBT MAREL Corp 2026: Revenue $981M, EPS $0.54— 10-Q Summary

JBT MAREL Corp (JBTM) reported its 2026 quarterly results, with revenue reaching $981M and diluted earnings per share at $0.54. This performance was driven by organic volume growth, positive foreign exchange translation, and improved margins, leading to a significant increase in net income to …

Reliance, Inc. $RS Position Reduced by Edgestream Partners L.P.

Edgestream Partners L.P. significantly reduced its stake in Reliance, Inc. (NYSE:RS) by 95.5% in the first quarter of 2026, selling 48,512 shares and retaining a smaller position. Despite this reduction and insider selling by company executives, Reliance reported strong Q1 earnings, beating analyst expectations …

Cracker Barrel Old Country Store (CBRL) Could Be 46% Above Fair Value Following CEO Change

Cracker Barrel Old Country Store (CBRL) has announced a new CEO, David Deno, taking over in August 2026. Despite a recent surge in share price, Simply Wall St suggests the company is 46.3% overvalued, with a fair value estimated at $39.50 compared to its …